These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial. Cornec-Le Gall E, Blais JD, Irazabal MV, Devuyst O, Gansevoort RT, Perrone RD, Chapman AB, Czerwiec FS, Ouyang J, Heyer CM, Senum SR, Le Meur Y, Torres VE, Harris PC. Nephrol Dial Transplant; 2018 Apr 01; 33(4):645-652. PubMed ID: 28992127 [Abstract] [Full Text] [Related]
4. Type of PKD1 mutation influences renal outcome in ADPKD. Cornec-Le Gall E, Audrézet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y. J Am Soc Nephrol; 2013 May 01; 24(6):1006-13. PubMed ID: 23431072 [Abstract] [Full Text] [Related]
5. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks E, Parfrey P, Torra R, San-Millan JL, Coto E, Van Dijk M, Breuning M, Peters D, Bogdanova N, Ligabue G, Albertazzi A, Hateboer N, Demetriou K, Pierides A, Deltas C, St George-Hyslop P, Ravine D, Pei Y. J Am Soc Nephrol; 2003 May 01; 14(5):1164-74. PubMed ID: 12707387 [Abstract] [Full Text] [Related]
6. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. Heyer CM, Sundsbak JL, Abebe KZ, Chapman AB, Torres VE, Grantham JJ, Bae KT, Schrier RW, Perrone RD, Braun WE, Steinman TI, Mrug M, Yu AS, Brosnahan G, Hopp K, Irazabal MV, Bennett WM, Flessner MF, Moore CG, Landsittel D, Harris PC, HALT PKD and CRISP Investigators. J Am Soc Nephrol; 2016 Sep 01; 27(9):2872-84. PubMed ID: 26823553 [Abstract] [Full Text] [Related]
7. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS. Clin J Am Soc Nephrol; 2006 Jul 01; 1(4):710-7. PubMed ID: 17699277 [Abstract] [Full Text] [Related]
8. Family history of renal disease severity predicts the mutated gene in ADPKD. Barua M, Cil O, Paterson AD, Wang K, He N, Dicks E, Parfrey P, Pei Y. J Am Soc Nephrol; 2009 Aug 01; 20(8):1833-8. PubMed ID: 19443633 [Abstract] [Full Text] [Related]
10. Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing. Kim H, Park HC, Ryu H, Kim H, Lee HS, Heo J, Lee C, Kim NKD, Park WY, Hwang YH, Lee KB, Oh KH, Oh YK, Ahn C. Sci Rep; 2019 Nov 18; 9(1):16952. PubMed ID: 31740684 [Abstract] [Full Text] [Related]
13. Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Torra R, Badenas C, Pérez-Oller L, Luis J, Millán S, Nicolau C, Oppenheimer F, Milà M, Darnell A. Am J Kidney Dis; 2000 Oct 18; 36(4):728-34. PubMed ID: 11007674 [Abstract] [Full Text] [Related]
14. Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing. Alzahrani OR, Alatwi HE, Alharbi AA, Alessa AH, Al-Amer OM, Alanazi AFR, Shams AM, Alomari E, Naser AY, Alzahrani FA, Hosawi S, Alghamdi SM, Abdali WA, Elfaki I, Hawsawi YM. Medicina (Kaunas); 2022 Nov 16; 58(11):. PubMed ID: 36422197 [Abstract] [Full Text] [Related]
15. Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. Ushio Y, Kataoka H, Sato M, Manabe S, Watanabe S, Akihisa T, Makabe S, Yoshida R, Tsuchiya K, Nitta K, Mochizuki T. Clin Exp Nephrol; 2020 Jun 16; 24(6):500-508. PubMed ID: 32036465 [Abstract] [Full Text] [Related]
16. Variation in age at ESRD in autosomal dominant polycystic kidney disease. Reed BY, McFann K, Bekheirnia MR, Nobakhthaghighi N, Masoumi A, Johnson AM, Shamshirsaz AA, Kelleher CL, Schrier RW. Am J Kidney Dis; 2008 Feb 16; 51(2):173-83. PubMed ID: 18215695 [Abstract] [Full Text] [Related]
17. Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease. Grau L, Gitomer B, McNair B, Wolf M, Harris P, Brosnahan G, Torres V, Steinman T, Yu A, Chapman A, Chonchol M, Nowak KL. Kidney360; 2020 Jul 16; 1(7):648-656. PubMed ID: 33305291 [Abstract] [Full Text] [Related]
18. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis. Higashihara E, Horie S, Kinoshita M, Harris PC, Okegawa T, Tanbo M, Hara H, Yamaguchi T, Shigemori K, Kawano H, Miyazaki I, Kaname S, Nutahara K. Clin Exp Nephrol; 2018 Apr 16; 22(2):395-404. PubMed ID: 28983800 [Abstract] [Full Text] [Related]
19. Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan. Higashihara E, Horie S, Muto S, Kawano H, Tambo M, Yamaguchi T, Taguchi S, Kaname S, Yokoyama K, Yoshioka T, Furukawa T, Fukuhara H. Am J Nephrol; 2020 Apr 16; 51(11):881-890. PubMed ID: 33227802 [Abstract] [Full Text] [Related]
20. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease. Chebib FT, Jung Y, Heyer CM, Irazabal MV, Hogan MC, Harris PC, Torres VE, El-Zoghby ZM. Nephrol Dial Transplant; 2016 Jun 16; 31(6):952-60. PubMed ID: 26932689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]